30 Participants Needed

Robotic Gait Training for Parkinson's Disease

PA
Overseen ByPeter Altenburger, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Indiana University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The purpose of this study is to investigate the implementation of a novel gait rehabilitation stimulus (G-EO System) that could advance current clinical practices. The goal is to establish the safety and feasibility of gait training using the G-EO System as well as investigating the impact on mobility, function, quality of life, and participatory outcomes. Research Design: We propose a single-blinded, randomized trial of electromechanically-assisted gait training using the G-EO System in patients with Parkinson's disease with gait disability. Specific Aim 1 will establish the safety and feasibility of gait training using the G-EO System. Specific Aim 2 will determine the efficacy of gait training using the G-EO System for improving mobility, function, and quality of life

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications, but it requires that your Parkinson's medication has been stable for the past 3 months.

What data supports the effectiveness of the treatment Robotic Gait Training for Parkinson's Disease?

Research shows that robot-assisted gait training can improve certain aspects of walking in people with Parkinson's disease, such as hip movement, compared to traditional treadmill training. This suggests that robotic gait training may be effective in enhancing walking abilities in these patients.12345

Is robotic gait training generally safe for humans?

Robotic gait training is generally safe, but it can cause some side effects like skin and tissue discomfort, musculoskeletal issues, and changes in blood pressure. These issues are often related to the pressure and alignment between the robot and the person using it.16789

How is the G-EO End-Effector Gait Trainer treatment different from other treatments for Parkinson's disease?

The G-EO End-Effector Gait Trainer is unique because it uses robotic technology to assist with walking, helping to improve movement patterns by targeting both the mechanics and the nervous system involved in walking. This approach is different from traditional physical therapy as it combines robotic assistance with real-world training, potentially offering more effective rehabilitation for gait issues in Parkinson's disease.134510

Eligibility Criteria

This trial is for adults over 18 with Parkinson's Disease at stages 1-3, who've been stable on their current medication for the last three months. They must have a Mini Mental State Exam score above 24 and physician approval to exercise. Those with severe movement issues or recent physical therapy are excluded.

Inclusion Criteria

My Parkinson's disease is in the early to mid-stage.
I have been diagnosed with Parkinson's Disease.
You scored higher than 24 on the Mini Mental State Examination.
See 5 more

Exclusion Criteria

I do not have conditions like bone instability that prevent G-EO gait training.
You weigh more than 150 kilograms.
You are shorter than 1 meter or taller than 2 meters.
See 4 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo electromechanically-assisted gait training using the G-EO System, administered 2 times per week for 40-60 minutes over six weeks

6 weeks
12 visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment, including assessments of walking speed, balance, and quality of life

4 weeks

Treatment Details

Interventions

  • Conventional Physical Therapy Treatment
  • G-EO End-Effector Gait Trainer
  • Robotic Gait Rehabilitation
Trial OverviewThe study tests a new robotic gait training system (G-EO System) against conventional physical therapy to see if it improves walking, function, and quality of life in Parkinson's patients. Participants will be randomly assigned to one of the treatments without knowing which one they're getting.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Conventional Physical Therapy (CPT) Group with G-EO Training (CPT-GEO)Experimental Treatment2 Interventions
CPT-GEO sessions will involve a warm-up using a cycle ergometer or treadmill walking, stretching, progressive strength training exercises, and balance training. Gait training will be administered using end-effector gait training protocols (G-EO trainer). Training will be administered 2 times per week for 40-60 minutes for six weeks.
Group II: Conventional Physical Therapy (CPT) GroupActive Control1 Intervention
CPT sessions will involve a warm-up using a cycle ergometer or treadmill walking, stretching, progressive strength training exercises, and balance training. Gait training will be provided using traditional over-ground walking. Additional strategies for home exercises, fall prevention, and appropriate assistive devices (i.e., orthotics) will be provided. Training will be administered 2 times per week for 40-60 minutes for six weeks.

G-EO End-Effector Gait Trainer is already approved in Switzerland, European Union for the following indications:

๐Ÿ‡จ๐Ÿ‡ญ
Approved in Switzerland as G-EO System for:
  • Neurological rehabilitation
  • Orthopedic rehabilitation
  • Gait disorders in Parkinson's disease
๐Ÿ‡ช๐Ÿ‡บ
Approved in European Union as G-EO System for:
  • Neurological rehabilitation
  • Orthopedic rehabilitation
  • Gait disorders in Parkinson's disease

Find a Clinic Near You

Who Is Running the Clinical Trial?

Indiana University

Lead Sponsor

Trials
1,063
Recruited
1,182,000+

Findings from Research

Robot-assisted gait therapy using the Lokomat system showed positive effects on gait parameters in a 67-year-old female with Parkinson's disease, including increased gait speed, stride length, and improved foot clearance after six training sessions.
The therapy also led to improvements in various aspects of the Unified Parkinson's Disease Rating Scale, such as motivation and bradykinesia, indicating potential benefits for overall mobility and quality of life, though more research is needed to compare its efficacy against traditional training methods.
Effect of robotic locomotor training in an individual with Parkinson's disease: a case report.Ustinova, K., Chernikova, L., Bilimenko, A., et al.[2011]
In a study involving 50 patients with Parkinson's disease, end-effector robotic rehabilitation training showed significant improvements in specific gait variables, indicating enhanced gait kinematics.
In contrast, intensive treadmill training did not result in any statistically significant changes in walking performance, suggesting that robotic therapy may be more effective for rehabilitation in mild Parkinson's disease.
Robot-assisted gait training versus treadmill training in patients with Parkinson's disease: a kinematic evaluation with gait profile score.Galli, M., Cimolin, V., De Pandis, MF., et al.[2019]
The study will compare the effects of functional kinematic therapy and overground wearable exoskeleton training on gait in 50 participants with Parkinson's Disease, evaluating changes in both peripheral and central nervous system function over three time points.
By integrating comprehensive gait analysis with neuromusculoskeletal modeling and brain activity assessments, the research aims to provide personalized treatment strategies for managing gait and postural disorders in Parkinson's Disease.
Quantitative assessment of training effects using EksoGTยฎ exoskeleton in Parkinson's disease patients: A randomized single blind clinical trial.Romanato, M., Spolaor, F., Beretta, C., et al.[2022]

References

Effect of robotic locomotor training in an individual with Parkinson's disease: a case report. [2011]
Robot-assisted gait training versus treadmill training in patients with Parkinson's disease: a kinematic evaluation with gait profile score. [2019]
Quantitative assessment of training effects using EksoGTยฎ exoskeleton in Parkinson's disease patients: A randomized single blind clinical trial. [2022]
Leg surface electromyography patterns in children with neuro-orthopedic disorders walking on a treadmill unassisted and assisted by a robot with and without encouragement. [2021]
Efficacy of rehabilitation robot-assisted gait training on lower extremity dyskinesia in patients with Parkinson's disease: A systematic review and meta-analysis. [2023]
Adaptive locomotor training on an end-effector gait robot: evaluation of the ground reaction forces in different training conditions. [2013]
Efficacy of end-effector Robot-Assisted Gait Training in subacute stroke patients: Clinical and gait outcomes from a pilot bi-centre study. [2020]
Occurrence and Type of Adverse Events During the Use of Stationary Gait Robots-A Systematic Literature Review. [2021]
Improving abnormal gait patterns by using a gait exercise assist robot (GEAR) in chronic stroke subjects: A randomized, controlled, pilot trial. [2021]
Robot-assisted gait training versus equal intensity treadmill training in patients with mild to moderate Parkinson's disease: a randomized controlled trial. [2013]